SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
Pappas Picks Likely Heir, Prepares for More IPOs
News | 09. 29. 2009
As Art Pappas makes plans for his eventual retirement, he's counting on the recent stock-market rebound to help some of the promising young companies he backs gain favor on Wall Street.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.